Literature DB >> 1576741

Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy.

G Hasenfuss1, L A Mulieri, B J Leavitt, P D Allen, J R Haeberle, N R Alpert.   

Abstract

Myocardial failure in dilated cardiomyopathy may result from subcellular alterations in contractile protein function, excitation-contraction coupling processes, or recovery metabolism. We used isometric force and heat measurements to quantitatively investigate these subcellular systems in intact left ventricular muscle strips from nonfailing human hearts (n = 14) and from hearts with end-stage failing dilated cardiomyopathy (n = 13). In the failing myocardium, peak isometric twitch tension, maximum rate of tension rise, and maximum rate of relaxation were reduced by 46% (p = 0.013), 51% (p = 0.003), and 46% (p = 0.018), respectively (37 degrees C, 60 beats per minute). Tension-dependent heat, reflecting the number of crossbridge interactions during the isometric twitch, was reduced by 61% in the failing myocardium (p = 0.006). In terms of the individual crossbridge cycle, the average crossbridge force-time integral was increased by 33% (p = 0.04) in the failing myocardium. In the nonfailing myocardium, the crossbridge force-time integral was positively correlated with the patient's age (r = 0.86, p less than 0.02), whereas there was no significant correlation with age in the failing group. The amount and rate of excitation-contraction coupling-related heat evolution (tension-independent heat) were reduced by 69% (p = 0.24) and 71% (p = 0.028), respectively, in the failing myocardium, reflecting a considerable decrease in the amount of calcium released and in the rate of calcium removal. The efficiency of the metabolic recovery process, as assessed by the ratio of initial heat to total activity-related heat, was similar in failing and nonfailing myocardium (0.54 +/- 0.03 versus 0.50 +/- 0.02, p = 0.23).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576741     DOI: 10.1161/01.res.70.6.1225

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.

Authors:  B Pieske; M Sütterlin; S Schmidt-Schweda; K Minami; M Meyer; M Olschewski; C Holubarsch; H Just; G Hasenfuss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.

Authors:  M R Wolff; S H Buck; S W Stoker; M L Greaser; R M Mentzer
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Thick filament proteins and performance in human heart failure.

Authors:  Bradley M Palmer
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

4.  Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy.

Authors:  W Schillinger; M Meyer; G Kuwajima; K Mikoshiba; H Just; G Hasenfuss
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

5.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

6.  Evaluation of left ventricular mechanical work and energetics of normal hearts in SERCA2a transgenic rats.

Authors:  Guo-Xing Zhang; Koji Obata; Daisuke Takeshita; Shinichi Mitsuyama; Tamiji Nakashima; Akio Kikuta; Masumi Hirabayashi; Koichi Tomita; Roland Vetter; Wolfgang H Dillmann; Miyako Takaki
Journal:  J Physiol Sci       Date:  2012-03-01       Impact factor: 2.781

Review 7.  Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

Authors:  Hashim Khan; Marco Metra; John E A Blair; Mark Vogel; Matthew E Harinstein; Gerasimos S Filippatos; Hani N Sabbah; Herve Porchet; Giovanni Valentini; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2009-02-24       Impact factor: 4.214

8.  Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin.

Authors:  J N Peterson; R Nassar; P A Anderson; N R Alpert
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

Review 9.  In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies.

Authors:  V Veksler; R Ventura-Clapier
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

Review 10.  The Need for Speed: Mice, Men, and Myocardial Kinetic Reserve.

Authors:  Paul M L Janssen; Brandon J Biesiadecki; Mark T Ziolo; Jonathan P Davis
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.